Literature DB >> 32503845

SETDB1 is required for intestinal epithelial differentiation and the prevention of intestinal inflammation.

Lea Južnić1,2, Kenneth Peuker1,2, Anne Strigli1,2, Mario Brosch1,2, Alexander Herrmann1,2, Robert Häsler3, Michael Koch1,2, Liz Matthiesen1,2, Yvonne Zeissig4, Britt-Sabina Löscher3, Alexander Nuber5, Gunnar Schotta5, Volker Neumeister6, Triantafyllos Chavakis6, Thomas Kurth7, Mathias Lesche8, Andreas Dahl8, Anne von Mässenhausen9,10, Andreas Linkermann9,10, Stefan Schreiber3,11, Konrad Aden3,11, Philip C Rosenstiel3, Andre Franke3, Jochen Hampe1,2, Sebastian Zeissig12,2.   

Abstract

OBJECTIVE: The intestinal epithelium is a rapidly renewing tissue which plays central roles in nutrient uptake, barrier function and the prevention of intestinal inflammation. Control of epithelial differentiation is essential to these processes and is dependent on cell type-specific activity of transcription factors which bind to accessible chromatin. Here, we studied the role of SET Domain Bifurcated Histone Lysine Methyltransferase 1, also known as ESET (SETDB1), a histone H3K9 methyltransferase, in intestinal epithelial homeostasis and IBD.
DESIGN: We investigated mice with constitutive and inducible intestinal epithelial deletion of Setdb1, studied the expression of SETDB1 in patients with IBD and mouse models of IBD, and investigated the abundance of SETDB1 variants in healthy individuals and patients with IBD.
RESULTS: Deletion of intestinal epithelial Setdb1 in mice was associated with defects in intestinal epithelial differentiation, barrier disruption, inflammation and mortality. Mechanistic studies showed that loss of SETDB1 leads to de-silencing of endogenous retroviruses, DNA damage and intestinal epithelial cell death. Predicted loss-of-function variants in human SETDB1 were considerably less frequently observed than expected, consistent with a critical role of SETDB1 in human biology. While the vast majority of patients with IBD showed unimpaired mucosal SETDB1 expression, comparison of IBD and non-IBD exomes revealed over-representation of individual rare missense variants in SETDB1 in IBD, some of which are predicted to be associated with loss of function and may contribute to the pathogenesis of intestinal inflammation.
CONCLUSION: SETDB1 plays an essential role in intestinal epithelial homeostasis. Future work is required to investigate whether rare variants in SETDB1 contribute to the pathogenesis of IBD. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  IBD; IBD - genetics; epithelial differentiation; gut inflammation; intestinal epithelium

Year:  2020        PMID: 32503845     DOI: 10.1136/gutjnl-2020-321339

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis.

Authors:  Shuhei Ueshima; Jia Fang
Journal:  Oncogene       Date:  2022-05-11       Impact factor: 9.867

Review 2.  Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance.

Authors:  Jan Padeken; Stephen P Methot; Susan M Gasser
Journal:  Nat Rev Mol Cell Biol       Date:  2022-05-13       Impact factor: 113.915

Review 3.  Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response.

Authors:  Jau-Ling Huang; Si-Yun Chen; Chang-Shen Lin
Journal:  J Pers Med       Date:  2022-04-01

Review 4.  Role of Epigenetics in the Regulation of Immune Functions of the Skin.

Authors:  Yu Sawada; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2020-11-27       Impact factor: 8.551

Review 5.  Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease.

Authors:  Manasvini Markandey; Aditya Bajaj; Nicholas Edward Ilott; Saurabh Kedia; Simon Travis; Fiona Powrie; Vineet Ahuja
Journal:  Gut Microbes       Date:  2021 Jan-Dec

6.  Enhanced expression of endogenous retroviruses and of TRIM28 and SETDB1 in children with food allergy.

Authors:  Pier-Angelo Tovo; Giovanna Monti; Valentina Daprà; Paola Montanari; Cristina Calvi; Carla Alliaudi; Allegra Sardo; Ilaria Galliano; Massimiliano Bergallo
Journal:  Clin Transl Allergy       Date:  2022-03       Impact factor: 5.871

7.  Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin.

Authors:  Stefan Bornstein; Igor Shapiro; Maria Malyukov; Richard Züllig; Edlira Luca; Evgeny Gelfgat; Felix Beuschlein; Svenja Nölting; Alfredo Berruti; Sandra Sigala; Mirko Peitzsch; Charlotte Steenblock; Barbara Ludwig; Patrick Kugelmeier; Constanze Hantel
Journal:  Cell Death Dis       Date:  2022-07-25       Impact factor: 9.685

Review 8.  SETDB1 in cancer: overexpression and its therapeutic implications.

Authors:  Vanessa J Lazaro-Camp; Kiarash Salari; Xiangbing Meng; Shujie Yang
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

9.  Complete loss of H3K9 methylation dissolves mouse heterochromatin organization.

Authors:  Thomas Montavon; Nicholas Shukeir; Galina Erikson; Bettina Engist; Megumi Onishi-Seebacher; Devon Ryan; Yaarub Musa; Gerhard Mittler; Alexandra Graff Meyer; Christel Genoud; Thomas Jenuwein
Journal:  Nat Commun       Date:  2021-07-16       Impact factor: 14.919

Review 10.  The role of regulated necrosis in endocrine diseases.

Authors:  Wulf Tonnus; Alexia Belavgeni; Felix Beuschlein; Graeme Eisenhofer; Martin Fassnacht; Matthias Kroiss; Nils P Krone; Martin Reincke; Stefan R Bornstein; Andreas Linkermann
Journal:  Nat Rev Endocrinol       Date:  2021-06-16       Impact factor: 47.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.